What Researchers Did
Researchers conducted a comprehensive review of 11 studies to investigate the feasibility and efficacy of hyperbaric oxygen therapy (HBOT) for radiation necrosis following radiotherapy for intracranial pathologies.
What They Found
The review included 11 studies with a total of 46 patients, primarily diagnosed with brain tumors or arteriovenous malformations. Most cases showed improvement in clinical and radiological outcomes, with HBOT proving to be a feasible and well-tolerated therapeutic option. Complications were generally mild and reversible.
What This Means for Canadian Patients
For Canadian patients experiencing radiation necrosis after intracranial radiotherapy, hyperbaric oxygen therapy may offer a noninvasive alternative when standard treatments are ineffective or not tolerated. This therapy could help resolve necrosis through angiogenesis, anti-inflammatory modulation, and cellular repair.
Canadian Relevance
This review does not indicate any specific Canadian connection or data.
Study Limitations
A limitation of this review is the small number of included studies and patients (11 studies, 46 patients), which may limit the generalizability of the findings.